Invasion and Angiogenesis in Malignant Gliomas
恶性胶质瘤的侵袭和血管生成
基本信息
- 批准号:7218651
- 负责人:
- 金额:$ 26.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:17-(Allylamino)-17-demethoxygeldanamycinAddressAnimal ModelAntibodiesApoptosisAppendixBindingBinding ProteinsBiological AvailabilityBiological ProcessBrainBrain NeoplasmsCOS-7 CellCell LineCellsCultured CellsDiffuseDominant-Negative MutationDown-RegulationElectronic MailEndothelial CellsExtracellular MatrixExtracellular Signal Regulated KinasesFocal Adhesion Kinase 1Focal AdhesionsFutureGelatinase AGelatinase BGeldanamycin AnalogueGenerationsGenetic TranscriptionGlioblastomaGliomaGoalsGrowthHeat-Shock Proteins 90HepatotoxicityHumanImmigrationImmunohistochemistryImplantIn VitroIntegrinsInvadedInvasiveLeadLocalizedMEKsMMP2 geneMMP9 geneMalignant GliomaMalignant neoplasm of prostateMediatingMigration AssayMitogen-Activated Protein KinasesModelingMolecularMolecular ChaperonesMonitorMusOperative Surgical ProceduresOutcomePathway interactionsPatientsPhosphorylationPhosphotransferasesPlasmaPlayProcessProtein KinaseProtein OverexpressionProteinsRadiation therapyReagentRoleSeedsSignal PathwaySignal Transduction PathwaySmall Interfering RNASolid NeoplasmTechniquesTestingTherapeuticToxic effectTransfectionTumor Cell InvasionVascular Endothelial Growth FactorsWateranalogangiogenesisbrain tissuecancer cellcell motilitychemotherapydesignhypoxia inducible factor 1improvedin vitro Assayin vivoin vivo Modelinhibitor/antagonistkinase inhibitorneoplastic cellnoveloutcome forecastpreventresearch studysuccesssurface coatingtumortumor growthtumor progression
项目摘要
DESCRIPTION (provided by applicant): There is a dire need for novel therapy for brain tumors. Diffuse glioma cell invasion into surrounding brain tissue and angiogenesis are fundamental features of gliomas that have not been successfully addressed by conventional therapy to control tumor growth in brain tumor patients. Current aggressive local treatments such as surgery, radiotherapy and chemotherapy are effective at controlling the localized mass of tumor cells in the brain. This success is only temporary, because tumor cells that have already invaded into the surrounding brain and serve as seeds by which the tumor re-grows. The process by which these tumor cells invade into the brain is not well understood. New treatment approaches that are capable to control these invading tumor cells can have a dramatic impact on patient outcome. We have developed assays in vitro and in vivo that allow us to study invading glioma and endothelial cells.
Our long-term goal remains to interfere with tumor invasion and angiogenesis to diminish tumor growth. To this end we propose i) to determine mechanisms involved in the migration of both endothelial and glioma cells; and ii) to investigate the mechanism and therapeutic potential of two geldanamycin analogues on glioma in vitro and in vivo.
Our proposal seeks to take advantage of new molecular biologic techniques to improve our understanding of this process. Collectively, the proposed experiments will analyze the cellular and molecular pathways necessary for tumor invasion and angiogenesis. Results from these experiments will lead to future strategies designed to inhibit specific molecular components implicated in these critical processes.
描述(由申请人提供):迫切需要用于脑肿瘤的新疗法。弥漫性神经胶质瘤细胞侵入周围脑组织和血管生成是神经胶质瘤的基本特征,其尚未通过常规疗法成功地解决以控制脑肿瘤患者中的肿瘤生长。目前积极的局部治疗,如手术,放疗和化疗是有效的控制肿瘤细胞在大脑中的局部质量。这种成功只是暂时的,因为肿瘤细胞已经侵入周围的大脑,并作为肿瘤重新生长的种子。这些肿瘤细胞侵入大脑的过程尚不清楚。能够控制这些入侵肿瘤细胞的新治疗方法可以对患者的预后产生巨大影响。我们已经开发了体外和体内试验,使我们能够研究入侵的胶质瘤和内皮细胞。
我们的长期目标仍然是干扰肿瘤侵袭和血管生成,以减少肿瘤生长。为此,我们建议i)确定参与内皮细胞和胶质瘤细胞迁移的机制; ii)研究两种格尔德霉素类似物在体外和体内对胶质瘤的机制和治疗潜力。
我们的建议旨在利用新的分子生物学技术来提高我们对这一过程的理解。总的来说,拟议的实验将分析肿瘤侵袭和血管生成所需的细胞和分子途径。这些实验的结果将导致未来的策略,旨在抑制这些关键过程中涉及的特定分子组分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID ZAGZAG其他文献
DAVID ZAGZAG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID ZAGZAG', 18)}}的其他基金
Identification and molecular characterization of FGFR4 p.G388R variant signaling in cerebellar hemangioblastomas
小脑血管母细胞瘤中 FGFR4 p.G388R 变异信号的鉴定和分子特征
- 批准号:
10450056 - 财政年份:2021
- 资助金额:
$ 26.28万 - 项目类别:
Identification and molecular characterization of FGFR4 p.G388R variant signaling in cerebellar hemangioblastomas
小脑血管母细胞瘤中 FGFR4 p.G388R 变异信号的鉴定和分子特征
- 批准号:
10290623 - 财政年份:2021
- 资助金额:
$ 26.28万 - 项目类别:
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
阻断贝伐珠单抗诱导的神经胶质瘤传播的新型 CXCR4 疗法。
- 批准号:
8249597 - 财政年份:2011
- 资助金额:
$ 26.28万 - 项目类别:
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
阻断贝伐珠单抗诱导的神经胶质瘤传播的新型 CXCR4 疗法。
- 批准号:
8338825 - 财政年份:2011
- 资助金额:
$ 26.28万 - 项目类别:
Intranasal Drug Delivery to Inhibit Glioma Angiogenesis and Invasion
鼻内给药抑制胶质瘤血管生成和侵袭
- 批准号:
7895050 - 财政年份:2009
- 资助金额:
$ 26.28万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 26.28万 - 项目类别:
Research Grant